BioCentury
ARTICLE | Company News

Ablexis, J&J deal

February 24, 2017 9:33 PM UTC

Ablexis granted Johnson & Johnson’s Janssen Biotech Inc. unit perpetual, non-exclusive rights to use Ablexis' AlivaMab Mouse transgenic mouse platform for antibody drug discovery and development. Able...

BCIQ Company Profiles

Ablexis LLC

Johnson & Johnson